Hypertension, a moving target in COVID-19: current views and perspectives
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …
Individualized beta-blocker treatment for high blood pressure dictated by medical comorbidities: indications beyond the 2018 European Society of Cardiology …
G Mancia, SE Kjeldsen, R Kreutz, A Pathak… - …, 2022 - Am Heart Assoc
Several hypertension guidelines have removed beta-blockers from their previous position as
first-choice drugs for the treatment of hypertension. However, this downgrading may not be …
first-choice drugs for the treatment of hypertension. However, this downgrading may not be …
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
A Kasiakogias, EA Rosei, M Camafort… - Journal of …, 2021 - journals.lww.com
Hypertension constitutes a major risk factor for heart failure with preserved ejection fraction
(HFpEF). HFpEF is a prevalent clinical syndrome with increased cardiovascular morbidity …
(HFpEF). HFpEF is a prevalent clinical syndrome with increased cardiovascular morbidity …
[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Heart failure with preserved ejection fraction—a concise review
Abstract Purpose of Review Heart failure with preserved ejection fraction (HFpEF) is a
relatively new disease entity used in medical terminology; however, both the number of …
relatively new disease entity used in medical terminology; however, both the number of …
NADPH oxidases in diastolic dysfunction and heart failure with preserved ejection fraction
JP Teuber, K Essandoh, SL Hummel, NR Madamanchi… - Antioxidants, 2022 - mdpi.com
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases regulate production of
reactive oxygen species (ROS) that cause oxidative damage to cellular components but also …
reactive oxygen species (ROS) that cause oxidative damage to cellular components but also …
[HTML][HTML] Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results
HU Kumar, BD Nearing, S Mittal, RK Premchand… - International journal of …, 2023 - Elsevier
Background Autonomic regulation therapy (ART) utilizing cervical vagus nerve stimulation
(VNS) appeared to be safe and to improve autonomic tone, symptoms, and cardiac …
(VNS) appeared to be safe and to improve autonomic tone, symptoms, and cardiac …
What is the current best drug treatment for hypertensive heart failure with preserved ejection fraction? Review of the totality of evidence
K Sevre, A Rist, K Wachtell, RB Devereux… - American Journal of …, 2024 - academic.oup.com
BACKGROUND More than 90% of patients developing heart failure (HF) have an
epidemiological background of hypertension. The most frequent concomitant conditions are …
epidemiological background of hypertension. The most frequent concomitant conditions are …
[HTML][HTML] The current best drug treatment for hypertensive heart failure with preserved ejection fraction
A Rist, K Sevre, K Wachtell, RB Devereux… - European journal of …, 2023 - Elsevier
More than 90% of patients developing heart failure (HF) have hypertension. The most
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …
frequent concomitant conditions are type-2 diabetes mellitus, obesity, atrial fibrillation, and …